GLP1R and polycystic ovary syndrome: The oxidative stress-induced follicular degeneration identified by Saber et al. and the progesterone suppression shown by Nishiyama et al. highlight concerns about the potential impact of GLP-1 receptor agonists on ovarian function in euglycemic, non-PCOS mice [31,32].